In this episode, Holmes Murphy Compliance Director Lance Lankford and Senior Advisor Den Bishop dig into the newest wave of healthcare cost pressures — from rising ACA premiums as enhanced subsidies expire to increasing demands for transparency in PBM practices and consumer drug pricing.

The main points we cover include:

• ACA Premium Pressure: What the expiration of enhanced subsidies means for marketplace rates and affordability.
• Drug Pricing Transparency: How momentum is building around PBM oversight and clearer consumer pharmacy costs.
• TrumpRx & Medicare Advantage Outlook: Early takeaways from the TrumpRx rollout and new MedPAC signals suggesting limited MA funding growth heading into 2027.
• The Politics of Affordability: How both parties are framing healthcare around one shared priority: lowering costs for consumers and employers.